PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-13.40%
Both companies show declining cash positions (-13.40% vs AXSM's -8.24%). Seth Klarman would examine if this reflects broader market conditions or operational challenges.
No Data
No Data available this quarter, please select a different quarter.
-13.40%
Cash + STI yoy ≥ 1.5x AXSM's -8.24%. David Dodd might see it as a strategic cash buffer advantage. Evaluate deployment plans.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-12.47%
≥ 1.5x AXSM's -8.09%. David Dodd might see a short-term liquidity advantage or potential underutilized capital.
8.92%
Below half AXSM's 51.28%. Michael Burry sees potential underinvestment risk unless there's a valid reason (asset-light model).
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
55.91%
0.5-0.75x AXSM's 91.07%. Martin Whitman wonders if there's insufficient reinvestment vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-12.20%
≥ 1.5x AXSM's -8.00%. David Dodd notes a larger balance sheet expansion. Confirm it's not overleveraged.
25.71%
Less than half of AXSM's -3.27%. David Dodd sees a more disciplined AP approach or lower volume.
-32.96%
Higher Short-Term Debt Growth compared to AXSM's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-56.33%
Higher Other Current Liabilities Growth compared to AXSM's zero value, indicating worse performance.
-28.78%
Less than half of AXSM's 48.70%. David Dodd sees a more disciplined short-term liability approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-28.78%
Less than half of AXSM's 48.70%. David Dodd sees far fewer liability expansions relative to competitor.
1.95%
Higher Common Stock (Book Value) Growth compared to AXSM's zero value, indicating worse performance.
-3.92%
Below half AXSM's -31.22%. Michael Burry suspects major net losses or high dividends vs. competitor.
-19.50%
Higher AOCI Growth compared to AXSM's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
-8.72%
Below half AXSM's 319.46%. Michael Burry sees potential underperformance in building shareholder capital.
-12.20%
Below half AXSM's 379.44%. Michael Burry sees significant shrinkage or inactivity vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-32.96%
Higher Total Debt Growth compared to AXSM's zero value, indicating worse performance.
13.20%
Above 1.5x AXSM's 8.24%. Michael Burry sees a major gap in net debt growth. Check coverage and liquidity.